CRDF vs ED · rev $145.0K vs P/E 18, rev $16.92B
Cardiff Oncology Inc (CRDF) versus Consolidated Edison Inc (ED) — a side-by-side from cached financials, not a winner call.
Cardiff Oncology Inc (CRDF) is a biotechnology company listed on US.
Consolidated Edison Inc (ED) is a utilities - regulated electric company listed on US.
Latest reported CRDF revenue for 2026-06-30 was $145.0K. Net income was -$21.6M. CRDF currently screens at market cap $238.8M.
Latest reported ED revenue for 2025-12-31 was $16.92B. Net income was $2.02B. Revenue was up 10.9% from 2024-12-31 to 2025-12-31. ED currently screens at market cap $36.02B and trailing P/E 18.3.
CRDF currently screens at market cap $238.8M. ED currently screens at market cap $36.02B and trailing P/E 18.3.
Not investment advice. Open the CRDF and ED stock pages for the full models.
Not investment advice.